Hematopoietic cell transplantation (HCT) is a complex treatment for several hematological disease groups, including many types of cancer. In a new study published in AJMC, researchers found that low risk HCT patients have had similar survival outcomes irrespective of whether they underwent transplant at higher- or lower-risk centers, even when they adjusted for sociodemographics.
The research conducted by University of Minnesota health policy experts Drs. Schelomo Marmor in the Department of Surgery, with James W. Begun, Jean Abraham and Beth A. Virnig, in the Department of Health Policy and Management. The research group wanted to investigate if facilities that developed an expertise with high risk HCT patients influenced their ability to treat lower risk HCT patients.